Literature DB >> 10477265

Inhibition of glycogenolysis in primary rat hepatocytes by 1, 4-dideoxy-1,4-imino-D-arabinitol.

B Andersen1, A Rassov, N Westergaard, K Lundgren.   

Abstract

1,4-Dideoxy-1,4-imino-d-arabinitol (DAB) was identified previously as a potent inhibitor of both the phosphorylated and non-phosphorylated forms of glycogen phosphorylase (EC 2.4.1.1). In the present study, the effects of DAB were investigated in primary cultured rat hepatocytes. The transport of DAB into hepatocytes was dependent on time and DAB concentration. The rate of DAB transport was 192 pmol/min per mg of protein per mM DAB(medium-concentration). In hepatocytes, DAB inhibited basal and glucagon-stimulated glycogenolysis with IC(50) values of 1.0+/-0.3 and 1.1+/-0.2 microM, respectively. The primary inhibitory effect of DAB on glycogenolysis was shown to be due to inhibition of glycogen phosphorylase but, at higher concentrations of DAB, inhibition of the debranching enzyme (4-alpha-glucanotransferase, EC 2.4.1.25) may have an effect. No effects on glycogen synthesis were observed, demonstrating that glycogen recycling does not occur in cultured hepatocytes under the conditions tested. Furthermore, DAB had no effects on phosphorylase kinase, the enzyme responsible for phosphorylation and thereby activation of glycogen phosphorylase, or on protein phosphatase 1, the enzyme responsible for inactivation of glycogen phosphorylase through dephosphorylation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10477265      PMCID: PMC1220495     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

Review 1.  The structure, role, and regulation of type 1 protein phosphatases.

Authors:  M Bollen; W Stalmans
Journal:  Crit Rev Biochem Mol Biol       Date:  1992       Impact factor: 8.250

2.  Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR.

Authors:  D L Rothman; I Magnusson; L D Katz; R G Shulman; G I Shulman
Journal:  Science       Date:  1991-10-25       Impact factor: 47.728

3.  1-Deoxynojirimycin and related compounds inhibit glycogenolysis in the liver without affecting the concentration of phosphorylase a.

Authors:  M Bollen; A Vandebroeck; W Stalmans
Journal:  Biochem Pharmacol       Date:  1988-03-01       Impact factor: 5.858

Review 4.  Hepatic glucose metabolism and insulin resistance in NIDDM and obesity.

Authors:  E J Barrett; Z Liu
Journal:  Baillieres Clin Endocrinol Metab       Date:  1993-10

5.  Non-invasive tracing of liver intermediary metabolism in normal subjects and in moderately hyperglycaemic NIDDM subjects. Evidence against increased gluconeogenesis and hepatic fatty acid oxidation in NIDDM.

Authors:  F Diraison; V Large; H Brunengraber; M Beylot
Journal:  Diabetologia       Date:  1998-02       Impact factor: 10.122

6.  Glucose analogue inhibitors of glycogen phosphorylase: the design of potential drugs for diabetes.

Authors:  J L Martin; K Veluraja; K Ross; L N Johnson; G W Fleet; N G Ramsden; I Bruce; M G Orchard; N G Oikonomakos; A C Papageorgiou
Journal:  Biochemistry       Date:  1991-10-22       Impact factor: 3.162

7.  Deficiency in phosphorylase phosphatase activity despite elevated protein phosphatase type-1 catalytic subunit in skeletal muscle from insulin-resistant subjects.

Authors:  B L Nyomba; D L Brautigan; K K Schlender; W Wang; C Bogardus; D M Mott
Journal:  J Clin Invest       Date:  1991-11       Impact factor: 14.808

8.  Pathogenesis of NIDDM. A balanced overview.

Authors:  R A DeFronzo; R C Bonadonna; E Ferrannini
Journal:  Diabetes Care       Date:  1992-03       Impact factor: 19.112

9.  Absence of glycogen cycling in cultured rat hepatocytes.

Authors:  N Grunnet; S Jensen; J Dich
Journal:  Arch Biochem Biophys       Date:  1994-02-15       Impact factor: 4.013

10.  The antiglycogenolytic action of 1-deoxynojirimycin results from a specific inhibition of the alpha-1,6-glucosidase activity of the debranching enzyme.

Authors:  M Bollen; W Stalmans
Journal:  Eur J Biochem       Date:  1989-05-15
View more
  16 in total

1.  Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs.

Authors:  Tracy P Torres; Noriyasu Sasaki; E Patrick Donahue; Brooks Lacy; Richard L Printz; Alan D Cherrington; Judith L Treadway; Masakazu Shiota
Journal:  J Pharmacol Exp Ther       Date:  2011-03-01       Impact factor: 4.030

2.  Aquaporin-9 protein is the primary route of hepatocyte glycerol uptake for glycerol gluconeogenesis in mice.

Authors:  Sabina Jelen; Sören Wacker; Camilo Aponte-Santamaría; Martin Skott; Aleksandra Rojek; Urban Johanson; Per Kjellbom; Søren Nielsen; Bert L de Groot; Michael Rützler
Journal:  J Biol Chem       Date:  2011-11-11       Impact factor: 5.157

3.  4-C-Me-DAB and 4-C-Me-LAB - enantiomeric alkyl-branched pyrrolidine iminosugars - are specific and potent α-glucosidase inhibitors; acetone as the sole protecting group.

Authors:  Filipa P da Cruz; Scott Newberry; Sarah F Jenkinson; Mark R Wormald; Terry D Butters; Dominic S Alonzi; Shinpei Nakagawa; Frederic Becq; Caroline Norez; Robert J Nash; Atsushi Kato; George W J Fleet
Journal:  Tetrahedron Lett       Date:  2011-01-12       Impact factor: 2.415

4.  A glia-neuron alanine/ammonium shuttle is central to energy metabolism in bee retina.

Authors:  Jonathan A Coles; Jean-Louis Martiel; Karolina Laskowska
Journal:  J Physiol       Date:  2008-02-14       Impact factor: 5.182

Review 5.  Astrocytic glycogenolysis: mechanisms and functions.

Authors:  Leif Hertz; Junnan Xu; Dan Song; Ting Du; Baoman Li; Enzhi Yan; Liang Peng
Journal:  Metab Brain Dis       Date:  2014-04-18       Impact factor: 3.584

6.  The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.

Authors:  Birgitte Andersen; Niels Westergaard
Journal:  Biochem J       Date:  2002-10-15       Impact factor: 3.857

7.  Fructose modulates GLUT5 mRNA stability in differentiated Caco-2 cells: role of cAMP-signalling pathway and PABP (polyadenylated-binding protein)-interacting protein (Paip) 2.

Authors:  Florence Gouyon; Cercina Onesto; Veronique Dalet; Gilles Pages; Armelle Leturque; Edith Brot-Laroche
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

8.  Diverse effects of two allosteric inhibitors on the phosphorylation state of glycogen phosphorylase in hepatocytes.

Authors:  Theodore Latsis; Birgitte Andersen; Loranne Agius
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

9.  Glutamate receptor-dependent increments in lactate, glucose and oxygen metabolism evoked in rat cerebellum in vivo.

Authors:  Kirsten Caesar; Parastoo Hashemi; Aicha Douhou; Gilles Bonvento; Martyn G Boutelle; Anne B Walls; Martin Lauritzen
Journal:  J Physiol       Date:  2008-01-10       Impact factor: 5.182

10.  Metformin stimulates FGF21 expression in primary hepatocytes.

Authors:  Eva B Nygaard; Sara G Vienberg; Cathrine Ørskov; Harald S Hansen; Birgitte Andersen
Journal:  Exp Diabetes Res       Date:  2012-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.